Ken Griffin Vaneck ETF Tr Biotech ETF Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Vaneck ETF Tr Biotech ETF stock. As of the latest transaction made, Citadel Advisors LLC holds 5,776 shares of BBH stock, worth $955,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,776

Previous 21,814 73.52%

Holding current value

$955,639

Previous $3.87 Million 76.58%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$156.32 - $178.25 $2.51 Million - $2.86 Million	-16,038 Reduced 73.52%	5,776 $906,000
Q3 2024 Nov 14, 2024	BUY	$167.06 - $182.72 $3.64 Million - $3.99 Million	21,814 New	21,814 $3.87 Million
Q4 2023 Feb 14, 2024	BUY	$143.93 - $166.4 $233,310 - $269,734	1,621 Added 60.13%	4,317 $713,000
Q3 2023 Nov 14, 2023	SELL	$152.6 - $165.22 $2.68 Million - $2.9 Million	-17,542 Reduced 86.68%	2,696 $419,000
Q2 2023 Aug 14, 2023	BUY	$154.15 - $167.37 $2.17 Million - $2.36 Million	14,093 Added 229.34%	20,238 $3.16 Million
Q1 2023 May 15, 2023	BUY	$151.32 - $169.5 $929,861 - $1.04 Million	6,145 New	6,145 $996,000
Q3 2022 Nov 14, 2022	BUY	$136.76 - $163.51 $1.62 Million - $1.93 Million	11,834 New	11,834 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$132.48 - $167.33 $676,840 - $854,888	-5,109 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$148.02 - $186.49 $1.03 Million - $1.3 Million	-6,948 Reduced 57.63%	5,109 $828,000
Q4 2021 Feb 14, 2022	BUY	$182.1 - $202.87 $493,491 - $549,777	2,710 Added 28.99%	12,057 $0
Q3 2021 Nov 15, 2021	BUY	$195.25 - $220.75 $510,383 - $577,040	2,614 Added 38.82%	9,347 $1.89 Million
Q2 2021 Aug 16, 2021	SELL	$173.72 - $201.85 $1.91 Million - $2.22 Million	-11,021 Reduced 62.08%	6,733 $0
Q1 2021 May 17, 2021	SELL	$167.43 - $195.8 $903,284 - $1.06 Million	-5,395 Reduced 23.31%	17,754 $3.12 Million
Q4 2020 Feb 16, 2021	BUY	$152.3 - $177.17 $2.45 Million - $2.85 Million	16,114 Added 229.05%	23,149 $3.92 Million
Q3 2020 Nov 16, 2020	SELL	$150.86 - $177.04 $1.46 Million - $1.71 Million	-9,657 Reduced 57.85%	7,035 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$124.43 - $164.89 $390,336 - $517,259	3,137 Added 23.14%	16,692 $2.72 Million
Q1 2020 May 15, 2020	BUY	$114.53 - $144.75 $1.55 Million - $1.96 Million	13,555 New	13,555 $1.74 Million
Q4 2019 Feb 14, 2020	SELL	$114.81 - $142.85 $4.48 Million - $5.58 Million	-39,034 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$117.33 - $123.7 $81,896 - $86,342	698 Added 1.82%	39,034 $0
Q2 2019 Aug 14, 2019	SELL	N/A	-8,728 Reduced 18.54%	38,336 $4.96 Million
Q1 2019 May 15, 2019	BUY	N/A	25,547 Added 118.73%	47,064 $0
Q4 2018 Feb 14, 2019	BUY	N/A	17,806 Added 479.82%	21,517 $0
Q3 2018 Nov 13, 2018	BUY	N/A	3,711 New	3,711 $0

Others Institutions Holding BBH

# of Institutions

125

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About VANECK ETF TR BIOTECH ETF

Ticker BBH
Sector ETFs
Industry ETFs

More about BBH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account